132 related articles for article (PubMed ID: 6883305)
21. Reversal of deamination-related cytotoxicity of 5-methyl-2'-deoxycytidine by tetrahydrouridine in human leukemia cells.
Jekunen A; Vilpo JA
J Natl Cancer Inst; 1984 Nov; 73(5):1087-91. PubMed ID: 6593484
[TBL] [Abstract][Full Text] [Related]
22. 2',3'-Dideoxycytidine: regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis.
Balzarini J; Cooney DA; Dalal M; Kang GJ; Cupp JE; DeClercq E; Broder S; Johns DG
Mol Pharmacol; 1987 Dec; 32(6):798-806. PubMed ID: 2826994
[TBL] [Abstract][Full Text] [Related]
23. Alterations of pyrimidine and nucleic acid synthesis during adaptive growth of liver induced by nafenopin, a peroxisome proliferator. An in vivo study.
Seifert J; Mostecká H
Carcinogenesis; 1989 Aug; 10(8):1383-8. PubMed ID: 2473851
[TBL] [Abstract][Full Text] [Related]
24. Strategies for the measurement of the inhibitory effects of thymidine analogs on the activity of thymidylate synthase in intact murine leukemia L1210 cells.
Balzarini J; De Clercq E
Biochim Biophys Acta; 1984 Feb; 785(1-2):36-45. PubMed ID: 6696920
[TBL] [Abstract][Full Text] [Related]
25. Effects of cytosine arabinoside and hydroxyurea on the synthesis of deoxyribonucleotides and DNA replication in L1210 cells.
Matsumoto M; Rey DA; Cory JG
Adv Enzyme Regul; 1990; 30():47-59. PubMed ID: 2403036
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo studies of a promising antileukemic thymidine analogue, 5-hydroxymethyl-2' deoxyuridine.
Kahilainen L; Bergstrom D; Kangas L; Vilpo JA
Biochem Pharmacol; 1986 Dec; 35(23):4211-5. PubMed ID: 3790149
[TBL] [Abstract][Full Text] [Related]
27. Lack of specific correlation of the deoxycytidine triphosphate pool level with rate of DNA synthesis.
Walters RA; Ratliff RL
Biochim Biophys Acta; 1975 Dec; 414(3):221-30. PubMed ID: 1203255
[TBL] [Abstract][Full Text] [Related]
28. Rescue of thymidine cytotoxicity in L1210 ascites by elevated endogenous levels of deoxycytidine.
Egan EM; Sargent L; Rosowsky A; Kufe DW
Cancer Treat Rep; 1981; 65(9-10):853-60. PubMed ID: 7273018
[TBL] [Abstract][Full Text] [Related]
29. Depression of thymidylate synthetase activity in response to cytosine arabinoside.
Roberts D; Loehr EV
Cancer Res; 1972 Jun; 32(6):1160-9. PubMed ID: 4503638
[No Abstract] [Full Text] [Related]
30. Exclusion of exogenous 5-methyl-2'-deoxycytidine from DNA in human leukemic cells. A study with [2(-14)C]- and [methyl-14C]5-methyl-2'-deoxycytidine.
Jekunen A; Puukka M; Vilpo J
Biochem Pharmacol; 1983 Apr; 32(7):1165-8. PubMed ID: 6189494
[TBL] [Abstract][Full Text] [Related]
31. Inhibition by deoxycytidine, cytidine, and beta-cytosine arabinoside of the induction of alkaline phosphatase activity in HeLa cells.
Goz B; Orr C; Wharton W
J Natl Cancer Inst; 1980 Jun; 64(6):1355-61. PubMed ID: 6929374
[TBL] [Abstract][Full Text] [Related]
32. Studies directed toward testing the "channeling" hypothesis--ribonucleotides----DNA in leukemia L1210 cells.
Chiba P; Bacon PE; Cory JG
Biochem Biophys Res Commun; 1984 Sep; 123(2):656-62. PubMed ID: 6435617
[TBL] [Abstract][Full Text] [Related]
33. Tetrahydrouridine specifically facilitates deoxycytidine incorporation into herpes simplex virus DNA.
North TW; Mathews CK
J Virol; 1981 Mar; 37(3):987-93. PubMed ID: 6262539
[TBL] [Abstract][Full Text] [Related]
34. Antitumor activity and biochemical effects of cyclopentenyl cytosine in mice.
Moyer JD; Malinowski NM; Treanor SP; Marquez VE
Cancer Res; 1986 Jul; 46(7):3325-9. PubMed ID: 3708566
[TBL] [Abstract][Full Text] [Related]
35. Use of 5-trifluoromethyldeoxycytidine and tetrahydrouridine to circumvent catabolism and exploit high levels of cytidine deaminase in tumors to achieve DNA- and target-directed therapies.
Mekras JA; Boothman DA; Greer SB
Cancer Res; 1985 Nov; 45(11 Pt 1):5270-80. PubMed ID: 2932216
[TBL] [Abstract][Full Text] [Related]
36. Use of 5-fluorodeoxycytidine and tetrahydrouridine to exploit high levels of deoxycytidylate deaminase in tumors to achieve DNA- and target-directed therapies.
Mekras JA; Boothman DA; Perez LM; Greer S
Cancer Res; 1984 Jun; 44(6):2551-60. PubMed ID: 6539164
[TBL] [Abstract][Full Text] [Related]
37. 3-Deazauridine enhances the antileukemic action of 5-aza-2'-deoxycytidine and targets drug-resistance due to deficiency in deoxycytidine kinase.
Raynal NJ; Momparler LF; Rivard GE; Momparler RL
Leuk Res; 2011 Jan; 35(1):110-8. PubMed ID: 20510451
[TBL] [Abstract][Full Text] [Related]
38. Combinations of tetrahydrouridine and cytosine arabinoside in mouse tumors.
Kreis W; Hession C; Soricelli A; Scully K
Cancer Treat Rep; 1977 Oct; 61(7):1355-64. PubMed ID: 589601
[TBL] [Abstract][Full Text] [Related]
39. Incorporation of a potent antileukemic agent, 5-aza-2'-deoxycytidine, into DNA of cells from leukemic mice.
Veselý J; Cihák A
Cancer Res; 1977 Oct; 37(10):3684-9. PubMed ID: 71199
[TBL] [Abstract][Full Text] [Related]
40. Role of deoxycytidine kinase in the inhibitory activity of 5-substituted 2'-deoxycytidines and cytosine arabinosides on tumor cell growth.
Balzarini J; De Clercq E
Mol Pharmacol; 1983 Jan; 23(1):175-81. PubMed ID: 6306422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
